BDD Press Releases
Investment to respond to growth in demand for integrated services at UK drug delivery company BDD
Dec 14, 2020 Investment to respond to growth in demand for integrated…
Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis Meets Primary Endpoints; Positive Topline Results of Oral Brilacidin
Feb 13, 2020 Innovation Pharmaceuticals Phase 1 Trial of Brilacidin…
BDD signs agreement with Innovation Pharmaceuticals for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease
Jun 06, 2019 BDD signs agreement with Innovation Pharmaceuticals…
BDD appoints ex-AstraZeneca VP Joanne Kelley as non-executive director to the Board
Oct 12, 2018 BDD appoints ex-AstraZeneca VP Joanne Kelley as…
BDD Pharma and Cingulate Therapeutics announce license agreement with OralogiK™ enabled triple pulse
Sep 07, 2018 BDD Pharma and Cingulate Therapeutics announce license…
BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology
May 30, 2018 BDD Pharma secures license agreement with top pharma…
£2M backing from Archangels and SIB for UK drug delivery company BDD
Mar 20, 2018 £2M backing from Archangels and SIB for
UK drug…